Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
Cipla
Fuji
Accenture
Baxter
QuintilesIMS
Harvard Business School
AstraZeneca

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,204,257

« Back to Dashboard

Which drugs does patent 6,204,257 protect, and when does it expire?

Patent 6,204,257 protects LUSEDRA and is included in one NDA.

This patent has thirty-one patent family members in twenty-five countries.
Summary for Patent: 6,204,257
Title: Water soluble prodrugs of hindered alcohols
Abstract:The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
Inventor(s): Stella; Valentino J. (Lawrence, KS), Zygmunt; Jan J. (Longmont, CO), Georg; Ingrid Gunda (Lawrence, KS), Safadi; Muhammad S. (Nazareth, IL)
Assignee: Universtiy of Kansas (Lawrence, KS)
Application Number:09/131,385
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use; Delivery;

Drugs Protected by US Patent 6,204,257

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Eisai Inc LUSEDRA fospropofol disodium SOLUTION;INTRAVENOUS 022244-001 Dec 12, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y Y SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,204,257

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,244,718 Water soluble prodrugs of hindered alcohols ➤ Try a Free Trial
6,451,776 Water soluble prodrugs of hindered alcohols ➤ Try a Free Trial
6,872,838 Water soluble prodrugs of hindered alcohols ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,204,257

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 73479 ➤ Try a Free Trial
Turkey 200100772 ➤ Try a Free Trial
Slovenia 1102776 ➤ Try a Free Trial
Russian Federation 2235727 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Fuji
Argus Health
Accenture
Baxter
AstraZeneca
Cantor Fitzgerald
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.